.Merck beats earnings expectations, rears purchases overview on sturdy demand for top medications like Keytruda CNBCMerck & Co. (MRK United States) Beats Income Forecasts as Keytruda Purchases Rise BloombergMerck Stock: Pharma Titan Posts Tough Results, But Expectation Tumbles Short Client's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats income and also purchases requirements among Keytruda strength, yet provides mixed full-year overview MarketWatch.